|
| [January 24, 2013] |
 |
Apixio Appoints Jonathan Murray as Chief Business Development Officer
SAN MATEO, Calif. --(Business Wire)--
Apixio Inc, the leading provider of clinical data integration and big
data analytics in healthcare, announces the appointment of Jonathan
Murray as Chief Business Development Officer. Murray will lead strategic
sales and business development activities at Apixio.
Murray joins Apixio with over twenty years of experience in consulting,
business development and sales roles in the healthcare industry. Prior
to joining Apixio, Murray was Senior Vice President of Business
Development, and Mid-America Market Head for Aetna's Accountable Care
Solutions division where he led the implementation of commercial
Accountable Care Oranizations between Aetna and selected providers.
Prior to Aetna, Murray held sales and business development leadership
roles at two successful healthcare startups, Anvita Health and
Resolution Health, both acquired by Humana and Wellpoint, respectively.
Murray's deep experience and expertise in healthcare industry also stems
from his years as a Client Solutions Executive at IBM's (News - Alert) Global Business
Services Healthcare Practice.
"We are honored and excited that Jonathan has joined the Apixio team,"
noted Shawn Dastmalchi, CEO of Apixio. "Jonathan's unique insights into
the rapidly changing healthcare industry will deliver deep value to
Apixio's clients including payers, providers and technology partners.
His experience developing value-based performance programs will be
invaluable as our partners navigate this evolving healthcare
environment. We look forward to creating and deepening our strategic
partnerships with Jonathan's leadership and business development
efforts."
About Apixio Inc.
Privately held and based in San Mateo, California, Apixio Inc. is the
leading provider of clinical data integration and big data analytics in
healthcare. Apixio's cloud-based solutions help at-risk healthcare
organizations achieve optimal quality, cost and revenue objectives.
[ Back To IBM News 's Homepage ]
|